Instil Bio, Inc. — Form 10-Q
Filed August 13, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 5/100
What the filing says
CEO Bronson Crouch and CFO Sandeep Laumas certified the Q2 2026 10-Q (ended June 30, 2026, filed August 13, 2026) under Sarbanes-Oxley Sections 302 and 906. Both officers certified that the report complies with securities law, financial statements fairly present the company's condition and operations, disclosure controls are effective, and no material weaknesses or fraud involving management were identified in internal controls. No substantive business changes or financial data are disclosed in these certification exhibits.
Why this rating
Boilerplate SOX certifications are routine periodic disclosures with no substantive business, financial, or operational content. No transactions, deals, or material changes announced.
See more from August 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.